Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...

The Trump administration announced it will not finalize a rule proposed by the Biden administration that would have allowed ...

Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...

Patients taking Eli Lilly’s drug to combat obesity, Zepbound, lost more weight than those who took Novo Nordisk’s Wegovy in a ...

President Trump will introduce a "most favored nation" plan aimed at cutting Medicare drug prices by linking them to the ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he ...

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

The Trump plan won't be limited to Medicare prescriptions and will also target medications covered by Medicaid and private ...